7K6I
Carbonic Anhydrase II complexed with 4-(2-(3-phenylureido)ethylsulfonamido)benzenesulfonamide
Summary for 7K6I
Entry DOI | 10.2210/pdb7k6i/pdb |
Descriptor | Carbonic anhydrase 2, ZINC ION, 4-[({2-[(phenylcarbamoyl)amino]ethyl}sulfonyl)amino]benzene-1-sulfonamide, ... (6 entities in total) |
Functional Keywords | carbonic anhydrase, caii, caix inhibitor, structure guided drug design, structure activity relationship study, breast cancer, lyase, lyase-lyase inhibitor complex, lyase/lyase inhibitor |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 1 |
Total formula weight | 30720.07 |
Authors | Andring, J.T.,Singh, S.,McKenna, R. (deposition date: 2020-09-20, release date: 2020-12-23, Last modification date: 2023-10-18) |
Primary citation | Akgul, O.,Singh, S.,Andring, J.T.,McKenna, R.,Selleri, S.,Carta, F.,Angeli, A.,Supuran, C.T. Handling drug-target selectivity: A study on ureido containing Carbonic Anhydrase inhibitors. Eur.J.Med.Chem., 212:113035-113035, 2021 Cited by PubMed Abstract: Here we report the synthesis of a series of taurine substituted sulfonamide derivatives 1-29 having the ureido moiety installed at the tail section as selective inhibitors of the tumor associated human (h) Carbonic Anhydrase (CA; EC 4.2.1.1) IX and XII. The series was deeply investigated for their kinetic features which demonstrated a strong dependence on the ureido moiety. High resolution X-ray crystallographic investigation on selected ligand adducts complexed with hCA II and hCA IX-mimic revealed a strong correlation between the ureido moiety and the amino acid residues Q92 and Q67 in both the hCA II and hCA IX-mimic, contributing to highly stabilized ligand-protein complex. PubMed: 33303238DOI: 10.1016/j.ejmech.2020.113035 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.406 Å) |
Structure validation
Download full validation report